Analysed ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) News Sources
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
09-04-2026
yahoo.com
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
30-03-2026
yahoo.com
What is the current price of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The current price of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is $50.04.
ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) since the previous trading day is $-0.27.
ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) since the previous trading day is -0.5367%.
What is the most recent average sentiment score for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The most recent average sentiment score for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The most recent sentiment for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is .
SEC-8K** Filing Available For ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.